The Hindu·2 min read·medium

Dr. Reddy’s Srikakulam facility gets 3 U.S. FDA observations

T
The Hindu Bureau
Dr. Reddy’s Srikakulam facility gets 3 U.S. FDA observations
AI Summary

Dr. Reddy’s Laboratories received three observations from the U.S. FDA following an inspection of its Srikakulam manufacturing facility. The company stated it will address these findings within the required timeframe.

Dr. Reddy’s Laboratories has been issued three observations by the U.S. Food and Drug Administration (U.S. FDA) after an inspection of its facility in Srikakulam, Andhra Pradesh.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
businesshealth

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in